Shingrix
Payments companies reported to CMS as associated with Shingrix. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Shingrix, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Shingrix
These are the largest totals companies reported as associated with Shingrix. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Feldman | Laguna Hills, CA | Geriatric Medicine (Internal Medicine) | $216,341.95 |
| Richard Feldman | Indianapolis, IN | Family Medicine | $190,753.81 |
| Bradley Wasson | Arlington, TX | Family Medicine | $172,831.57 |
| Sean Leng | Baltimore, MD | Geriatric Medicine (Internal Medicine) | $165,071.73 |
| Derrick Butler | Los Angeles, CA | Family Medicine | $154,264.80 |
| Laurene Mascola | Los Angeles, CA | Pediatrics | $144,230.86 |
| Steven Burdette | Dayton, OH | Infectious Disease | $118,864.25 |
| Todd Ellerin | Boston, MA | Infectious Disease | $83,093.71 |
| Martin Mahoney | Buffalo, NY | Family Medicine | $77,794.58 |
| Bayo Curry-Winchell | Reno, NV | Family Medicine | $52,500.00 |
Prescribed Shingrix?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.